Market Report, "Primary Systemic Amyloidosis - Pipeline Review, H2 2012", Published
Global Markets Direct's, 'Primary Systemic Amyloidosis - Pipeline Review, H2 2012', provides an overview of the indication's therapeutic pipeline. This report provides information on the therapeutic development for Primary Systemic Amyloidosis, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Primary Systemic Amyloidosis. Primary Systemic Amyloidosis - Pipeline Review, Half Year is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites,...
View full press release